Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,003,021
-$229,285 QoQ
Shares Held
58,108
+53.9% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,988,604,613 across 26 Diagnostics & Research names. GRAL ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
4,627,126 | $1,234,563,487 | |
| 2 | DGX |
Quest Diagnostics Inc
|
1,846,336 | $361,844,929 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
627,704 | $308,535,347 | |
| 4 | RVTY |
Revvity, Inc.
|
3,372,627 | $295,475,851 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
1,296,289 | $221,069,125 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
743,346 | $128,227,185 | |
| 7 | NTRA |
Natera, Inc.
|
515,238 | $103,042,447 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
183,237 | $102,959,037 |
All Filings in GRAL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,003,021 | 58,108 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,232,306 | 37,765 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,651,146 | 27,924 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $311,426 | 20,262 | Shares | Sole | 2024-08-05 | |
| No filing history on record for this holder in this stock. | ||||||